Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Corgenix, Randox Complete IT Assay | Contract Pharma

What are you searching for?

Sign in
Breaking News

Corgenix, Randox Complete IT Assay

Corgenix Medical Corp. has successfully completed the feasibility stage for a new, high-speed automated test format for its AspirinWorks Test, developed in collaboration with Randox Laboratories.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Corgenix Medical Corp. has successfully completed the feasibility stage for a new, high-speed automated test format for its AspirinWorks Test, developed in collaboration with Randox Laboratories. The new format was created to make it faster and easier to perform the AspirinWorks Test at clinical labs and hospitals.

“We’ve taken another critical step forward in expanding the potential market for the AspirinWorks Test,” said Douglass Simpson, Corgenix president and chief executive. “The next step in this process will be the launch of the new fully automated immunoturbidimetric (IT) format, making it easier and faster to process large volumes of this important cardiovascular test.”

Once completed and approved by the FDA, the new IT assay will be compatible with automated chemistry analyzers. The assay will be manufactured at Randox Laboratories in the UK, and the two companies will share global distribution rights.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics